Salivary Mucoepidermoid Carcinoma: A Multi-Institutional Review of 76 Patients

Shuting Bai, Rashna Clubwala, Esther Adler, Cathy Sarta, Bradley A. Schiff, Richard V. Smith, Douglas R. Gnepp, Margaret Brandwein-Gensler

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Mucoepidermoid carcinoma (MEC) is a relatively common salivary tumor with varying potential for aggressive behavior. Mucoepidermoid carcinoma grading has evolved from descriptive two-tiered schemata to more objective three-tiered systems. In 2001, we published a grading system Brandwein et al. in Am J Surg Pathol 25:835-845, (2001) which modified the prevailing criteria of Auclair et al. in Cancer 69:2021-2030 (1992), and included additional features of aggressive MEC. Here we seek to validate our modified grading system in a new multicenter cohort. The retrospective cohort consisted of 76 patients with confirmed MEC and known outcome data. The resection specimens were reviewed and uniformly graded according to our modified criteria Brandwein et al. in Am J Surg Pathol 25:835-845 (2001), and the Auclair criteria Auclair et al. in Cancer 69:2021-2030, (1992), Goode et al. in Cancer 82:1217-1224, (1998). Case distribution was as follows: Montefiore Medical Center: 41 (1977-2009), University of Alabama at Birmingham: 21 (1999-2010), and Rhode Island Hospital: 14, (1995-2011). Patient age ranged from 7 to 81 years (mean 51 years). The female to male ratio was 3:1. The most commonly involved sites were: parotid: n = 39 (51 %), palate: n = 10 (13 %), retromolar trigone: n = 6 (8 %), buccal: n = 5 (7 %), and submandibular gland: n = 5 (7 %). The modified criteria upgraded 41 % MEC; 20/25 MEC from AFIP Grade 1 to Grade 2 and 5/25 from AFIP Grade 1 to Grade 3. Eleven patients had positive lymph nodes; the AFIP MEC grade for cases were: Grade 1-3/11, Grade 2-1/11, and Grade 3-7/11; the modified grading criteria distribution for these cases were Grade 1: 0/11, Grade 2: 1/11, and Grade 3: 10/11. Nine patients developed disease progression after definitive treatment. High-stage and positive lymph node status were significantly associated with disease progression (p = 0. 0003 and p < 0. 0001, respectively). For the nine patients with disease progression, the modified grading schema classified eight MEC as Grade 3 and one as Grade 2. By comparison, the AFIP grading schema classified three of these MEC as Grade 1, and the remaining six as Grade 3. Despite the fact that this multicenter retrospective study accrued 76 patients with outcome, the predictive performance of the two grading schema could not be compared due to the few patients who experienced disease progression and were also reclassified with respect to grade (n = 3).

Original languageEnglish (US)
Pages (from-to)105-112
Number of pages8
JournalHead and Neck Pathology
Volume7
Issue number2
DOIs
StatePublished - Jun 2013

Fingerprint

Mucoepidermoid Carcinoma
Disease Progression
Neoplasms
Lymph Nodes
Palate
Cheek
Submandibular Gland
Multicenter Studies
Retrospective Studies

Keywords

  • AFIP
  • Grading
  • Modified criteria
  • Mucoepidermoid carcinoma
  • Pattern of invasion

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Otorhinolaryngology

Cite this

Salivary Mucoepidermoid Carcinoma : A Multi-Institutional Review of 76 Patients. / Bai, Shuting; Clubwala, Rashna; Adler, Esther; Sarta, Cathy; Schiff, Bradley A.; Smith, Richard V.; Gnepp, Douglas R.; Brandwein-Gensler, Margaret.

In: Head and Neck Pathology, Vol. 7, No. 2, 06.2013, p. 105-112.

Research output: Contribution to journalArticle

Bai, S, Clubwala, R, Adler, E, Sarta, C, Schiff, BA, Smith, RV, Gnepp, DR & Brandwein-Gensler, M 2013, 'Salivary Mucoepidermoid Carcinoma: A Multi-Institutional Review of 76 Patients', Head and Neck Pathology, vol. 7, no. 2, pp. 105-112. https://doi.org/10.1007/s12105-012-0405-0
Bai, Shuting ; Clubwala, Rashna ; Adler, Esther ; Sarta, Cathy ; Schiff, Bradley A. ; Smith, Richard V. ; Gnepp, Douglas R. ; Brandwein-Gensler, Margaret. / Salivary Mucoepidermoid Carcinoma : A Multi-Institutional Review of 76 Patients. In: Head and Neck Pathology. 2013 ; Vol. 7, No. 2. pp. 105-112.
@article{30f8ead2fc3747abbdca5597d3b272f7,
title = "Salivary Mucoepidermoid Carcinoma: A Multi-Institutional Review of 76 Patients",
abstract = "Mucoepidermoid carcinoma (MEC) is a relatively common salivary tumor with varying potential for aggressive behavior. Mucoepidermoid carcinoma grading has evolved from descriptive two-tiered schemata to more objective three-tiered systems. In 2001, we published a grading system Brandwein et al. in Am J Surg Pathol 25:835-845, (2001) which modified the prevailing criteria of Auclair et al. in Cancer 69:2021-2030 (1992), and included additional features of aggressive MEC. Here we seek to validate our modified grading system in a new multicenter cohort. The retrospective cohort consisted of 76 patients with confirmed MEC and known outcome data. The resection specimens were reviewed and uniformly graded according to our modified criteria Brandwein et al. in Am J Surg Pathol 25:835-845 (2001), and the Auclair criteria Auclair et al. in Cancer 69:2021-2030, (1992), Goode et al. in Cancer 82:1217-1224, (1998). Case distribution was as follows: Montefiore Medical Center: 41 (1977-2009), University of Alabama at Birmingham: 21 (1999-2010), and Rhode Island Hospital: 14, (1995-2011). Patient age ranged from 7 to 81 years (mean 51 years). The female to male ratio was 3:1. The most commonly involved sites were: parotid: n = 39 (51 {\%}), palate: n = 10 (13 {\%}), retromolar trigone: n = 6 (8 {\%}), buccal: n = 5 (7 {\%}), and submandibular gland: n = 5 (7 {\%}). The modified criteria upgraded 41 {\%} MEC; 20/25 MEC from AFIP Grade 1 to Grade 2 and 5/25 from AFIP Grade 1 to Grade 3. Eleven patients had positive lymph nodes; the AFIP MEC grade for cases were: Grade 1-3/11, Grade 2-1/11, and Grade 3-7/11; the modified grading criteria distribution for these cases were Grade 1: 0/11, Grade 2: 1/11, and Grade 3: 10/11. Nine patients developed disease progression after definitive treatment. High-stage and positive lymph node status were significantly associated with disease progression (p = 0. 0003 and p < 0. 0001, respectively). For the nine patients with disease progression, the modified grading schema classified eight MEC as Grade 3 and one as Grade 2. By comparison, the AFIP grading schema classified three of these MEC as Grade 1, and the remaining six as Grade 3. Despite the fact that this multicenter retrospective study accrued 76 patients with outcome, the predictive performance of the two grading schema could not be compared due to the few patients who experienced disease progression and were also reclassified with respect to grade (n = 3).",
keywords = "AFIP, Grading, Modified criteria, Mucoepidermoid carcinoma, Pattern of invasion",
author = "Shuting Bai and Rashna Clubwala and Esther Adler and Cathy Sarta and Schiff, {Bradley A.} and Smith, {Richard V.} and Gnepp, {Douglas R.} and Margaret Brandwein-Gensler",
year = "2013",
month = "6",
doi = "10.1007/s12105-012-0405-0",
language = "English (US)",
volume = "7",
pages = "105--112",
journal = "Head and Neck Pathology",
issn = "1936-055X",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Salivary Mucoepidermoid Carcinoma

T2 - A Multi-Institutional Review of 76 Patients

AU - Bai, Shuting

AU - Clubwala, Rashna

AU - Adler, Esther

AU - Sarta, Cathy

AU - Schiff, Bradley A.

AU - Smith, Richard V.

AU - Gnepp, Douglas R.

AU - Brandwein-Gensler, Margaret

PY - 2013/6

Y1 - 2013/6

N2 - Mucoepidermoid carcinoma (MEC) is a relatively common salivary tumor with varying potential for aggressive behavior. Mucoepidermoid carcinoma grading has evolved from descriptive two-tiered schemata to more objective three-tiered systems. In 2001, we published a grading system Brandwein et al. in Am J Surg Pathol 25:835-845, (2001) which modified the prevailing criteria of Auclair et al. in Cancer 69:2021-2030 (1992), and included additional features of aggressive MEC. Here we seek to validate our modified grading system in a new multicenter cohort. The retrospective cohort consisted of 76 patients with confirmed MEC and known outcome data. The resection specimens were reviewed and uniformly graded according to our modified criteria Brandwein et al. in Am J Surg Pathol 25:835-845 (2001), and the Auclair criteria Auclair et al. in Cancer 69:2021-2030, (1992), Goode et al. in Cancer 82:1217-1224, (1998). Case distribution was as follows: Montefiore Medical Center: 41 (1977-2009), University of Alabama at Birmingham: 21 (1999-2010), and Rhode Island Hospital: 14, (1995-2011). Patient age ranged from 7 to 81 years (mean 51 years). The female to male ratio was 3:1. The most commonly involved sites were: parotid: n = 39 (51 %), palate: n = 10 (13 %), retromolar trigone: n = 6 (8 %), buccal: n = 5 (7 %), and submandibular gland: n = 5 (7 %). The modified criteria upgraded 41 % MEC; 20/25 MEC from AFIP Grade 1 to Grade 2 and 5/25 from AFIP Grade 1 to Grade 3. Eleven patients had positive lymph nodes; the AFIP MEC grade for cases were: Grade 1-3/11, Grade 2-1/11, and Grade 3-7/11; the modified grading criteria distribution for these cases were Grade 1: 0/11, Grade 2: 1/11, and Grade 3: 10/11. Nine patients developed disease progression after definitive treatment. High-stage and positive lymph node status were significantly associated with disease progression (p = 0. 0003 and p < 0. 0001, respectively). For the nine patients with disease progression, the modified grading schema classified eight MEC as Grade 3 and one as Grade 2. By comparison, the AFIP grading schema classified three of these MEC as Grade 1, and the remaining six as Grade 3. Despite the fact that this multicenter retrospective study accrued 76 patients with outcome, the predictive performance of the two grading schema could not be compared due to the few patients who experienced disease progression and were also reclassified with respect to grade (n = 3).

AB - Mucoepidermoid carcinoma (MEC) is a relatively common salivary tumor with varying potential for aggressive behavior. Mucoepidermoid carcinoma grading has evolved from descriptive two-tiered schemata to more objective three-tiered systems. In 2001, we published a grading system Brandwein et al. in Am J Surg Pathol 25:835-845, (2001) which modified the prevailing criteria of Auclair et al. in Cancer 69:2021-2030 (1992), and included additional features of aggressive MEC. Here we seek to validate our modified grading system in a new multicenter cohort. The retrospective cohort consisted of 76 patients with confirmed MEC and known outcome data. The resection specimens were reviewed and uniformly graded according to our modified criteria Brandwein et al. in Am J Surg Pathol 25:835-845 (2001), and the Auclair criteria Auclair et al. in Cancer 69:2021-2030, (1992), Goode et al. in Cancer 82:1217-1224, (1998). Case distribution was as follows: Montefiore Medical Center: 41 (1977-2009), University of Alabama at Birmingham: 21 (1999-2010), and Rhode Island Hospital: 14, (1995-2011). Patient age ranged from 7 to 81 years (mean 51 years). The female to male ratio was 3:1. The most commonly involved sites were: parotid: n = 39 (51 %), palate: n = 10 (13 %), retromolar trigone: n = 6 (8 %), buccal: n = 5 (7 %), and submandibular gland: n = 5 (7 %). The modified criteria upgraded 41 % MEC; 20/25 MEC from AFIP Grade 1 to Grade 2 and 5/25 from AFIP Grade 1 to Grade 3. Eleven patients had positive lymph nodes; the AFIP MEC grade for cases were: Grade 1-3/11, Grade 2-1/11, and Grade 3-7/11; the modified grading criteria distribution for these cases were Grade 1: 0/11, Grade 2: 1/11, and Grade 3: 10/11. Nine patients developed disease progression after definitive treatment. High-stage and positive lymph node status were significantly associated with disease progression (p = 0. 0003 and p < 0. 0001, respectively). For the nine patients with disease progression, the modified grading schema classified eight MEC as Grade 3 and one as Grade 2. By comparison, the AFIP grading schema classified three of these MEC as Grade 1, and the remaining six as Grade 3. Despite the fact that this multicenter retrospective study accrued 76 patients with outcome, the predictive performance of the two grading schema could not be compared due to the few patients who experienced disease progression and were also reclassified with respect to grade (n = 3).

KW - AFIP

KW - Grading

KW - Modified criteria

KW - Mucoepidermoid carcinoma

KW - Pattern of invasion

UR - http://www.scopus.com/inward/record.url?scp=84877046166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877046166&partnerID=8YFLogxK

U2 - 10.1007/s12105-012-0405-0

DO - 10.1007/s12105-012-0405-0

M3 - Article

C2 - 23080318

AN - SCOPUS:84877046166

VL - 7

SP - 105

EP - 112

JO - Head and Neck Pathology

JF - Head and Neck Pathology

SN - 1936-055X

IS - 2

ER -